Neovascular age ‐related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections

ConclusionTreatment of nAMD at a single centre in two sequential cohorts yielded comparable BCVA outcomes with 15% fewer injections of aflibercept compared to ranibizumab.

Source: Acta Ophthalmologica - July 31, 2016 Category: Opthalmology Authors: Annette Rasmussen, Birgit Sander, Michael Larsen, Sara Brandi, Josefine Fuchs, Louise H. Hansen, Henrik Lund ‐Andersen Tags: Original Article Source Type: research